EFFECT OF A METALLOTHIONEIN ANTISENSE OLIGONUCLEOTIDE ON EMBRYO DEVELOPMENT

被引:8
|
作者
PETERS, JM
DUNCAN, JR
WILEY, LM
RUCKER, RB
KEEN, CL
机构
[1] UNIV CALIF DAVIS,DEPT NUTR,DAVIS,CA 95616
[2] UNIV CALIF DAVIS,DEPT OBSTET & GYNECOL,DIV REPROD BIOL & MED,DAVIS,CA
[3] RHODES UNIV,DEPT BIOCHEM & MICROBIOL,GRAHAMSTOWN,SOUTH AFRICA
[4] UNIV CALIF DAVIS,DEPT INTERNAL MED,DAVIS,CA
关键词
PREIMPLANTATION DEVELOPMENT; EMBRYO; METALLOTHIONEIN; ANTISENSE DNA; CADMIUM TOXICITY; NUCLEOTIDE TOXICITY;
D O I
10.1016/0890-6238(94)00062-X
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The effect of a metallothionein (MT) antisense oligodeoxynucleotide (ODN) on mouse preimplantation embryo development was investigated. Preimplantation embryos were cultured for 72 h and examined following exposure to either an MT antisense or sense ODN. Blastocyst formation (cavitation) and embryo cell number were lower in embryos exposed to the MT antisense ODN than in controls or in embryos exposed to the MT sense ODN. In embryos cultured in medium containing free nucleotides, cavitation frequency was not affected, although mean embryo cell number was lower than in controls. Combined, this work shows that an antisense ODN against MT can significantly affect blastocyst formation of preimplantation embryos; some, but not all, of the observed effects on embryo cell number may have been due to nucleotide toxicity.
引用
收藏
页码:123 / 130
页数:8
相关论文
共 50 条
  • [41] Development of therapeutic antisense oligonucleotide against small cell lung cancer
    Shimojo, Masahito
    CANCER SCIENCE, 2018, 109 : 355 - 355
  • [42] A new antisense oligonucleotide therapy?
    Nicholas J. Bernard
    Nature Reviews Rheumatology, 2018, 14 : 685 - 685
  • [43] ANTISENSE OLIGONUCLEOTIDE STRATEGIES IN NEUROPHARMACOLOGY
    WAHLESTEDT, C
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (02) : 42 - 46
  • [44] STUDIES ON THE ANTISENSE OLIGONUCLEOTIDE CONJUGATE
    WANG, LX
    YANG, DC
    LU, YY
    TAKAKI, Y
    TAIRA, K
    LI, T
    ZHANG, LH
    JOURNAL OF THE CHINESE CHEMICAL SOCIETY, 1995, 42 (04) : 667 - 671
  • [45] Antisense Anticancer Oligonucleotide Therapeutics
    Wang, Hui
    Prasad, Gautam
    Buolamwini, John K.
    Zhang, Ruiwen
    CURRENT CANCER DRUG TARGETS, 2001, 1 (03) : 177 - 196
  • [46] ANTISENSE OLIGONUCLEOTIDE OF C-MYC DISCRIMINATES BETWEEN ZINC-INDUCED AND DEXAMETHASONE-INDUCED SYNTHESIS OF METALLOTHIONEIN
    TAKEDA, A
    NORRIS, JS
    IVERSEN, PL
    EBADI, M
    PHARMACOLOGY, 1994, 48 (02) : 119 - 126
  • [47] Targeted delivery of an antisense oligonucleotide in the retina: Uptake, distribution, stability, and effect
    Rakoczy, PE
    Lai, MC
    Watson, M
    Seydel, U
    Constable, I
    ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1996, 6 (03): : 207 - 213
  • [48] Differential effect of an antisense oligonucleotide to the transferrin receptor in hematopoietic cell lines correlates to subcellular distribution of the oligonucleotide
    Maia, LF
    Vasconcelos, MH
    Sousa, C
    Beleza, S
    Guimaraes, JE
    EXPERIMENTAL HEMATOLOGY, 2000, 28 (07) : 76 - 77
  • [49] THE EFFECT OF ANTISENSE OLIGONUCLEOTIDE THERAPY IN A MOUSE MODEL OF HUNTINGTON'S DISEASE
    Matthews, M.
    Tsanov, M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (SUPPL 1) : S36 - S36
  • [50] Effect of intrauterine injection of adrenomedullin antisense oligonucleotide during gestation in rats
    Shibata, Kazuhiko
    Yae, Tetsuji
    Sagara, Hidenori
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 248P - 248P